Zobrazeno 1 - 10
of 20
pro vyhledávání: '"B M, Markaverich"'
Publikováno v:
International journal of oncology. 2(3)
Methyl p-hydroxyphenyllactate (MeHPLA) is an endogenous ligand for nuclear type II sites which apparently regulates cellular growth and proliferation through this binding interaction. Occupancy of type II sites by MeHPLA agonists such as dihydroxyben
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0a6fc1ab33573343852c550f57816c
https://pubmed.ncbi.nlm.nih.gov/21573566
https://pubmed.ncbi.nlm.nih.gov/21573566
Publikováno v:
International journal of oncology. 4(6)
Previous studies from this laboratory demonstrated that 2,6-bis-([3,4-dihydroxyphenyl]methylene)cyclohexanone (BDHPC) and related compounds mimic methyl p-hydroxyphenyllactate (MeHPLA) as endogenous ligands for nuclear type II [H-3]estradiol binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::706083bce468581885cc8154603a2065
https://pubmed.ncbi.nlm.nih.gov/21567051
https://pubmed.ncbi.nlm.nih.gov/21567051
Autor:
B. M. Markaverich, M. A. Alejandro
Publikováno v:
International journal of oncology. 11(6)
Previous studies from this laboratory have shown that bioflavonoids including luteolin and quercetin possess antiestrogenic activity in the female reproductive tract and appear to elicit this activity by interaction with type II [H-3]estradiol bindin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4897f19f597b2623bf7ccd64bc8e64d
https://pubmed.ncbi.nlm.nih.gov/21528340
https://pubmed.ncbi.nlm.nih.gov/21528340
Autor:
S Krnacik, L C Stephens, B M Markaverich, Lakshmi Sivaraman, O M Conneely, B W O'Malley, J A Clark, Daniel Medina
Publikováno v:
Carcinogenesis. 19(9)
One of the most consistent results in the epidemiology of human breast cancer is the inverse relationship of risk and early full-term parity. The goal of this study was to investigate the molecular mechanisms through which early full-term pregnancy p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88755eae318086a238b7fe01b8ce2462
https://pubmed.ncbi.nlm.nih.gov/9771927
https://pubmed.ncbi.nlm.nih.gov/9771927
Autor:
B. M. Markaverich, M. A. Alejandro
Publikováno v:
International Journal of Oncology.
A number of studies from our laboratory and others have shown that synthetic and naturally occurring bioflavonoids and related compounds have significant antiproliferative activity in the rat uterus and mouse mammary tumor model systems. This cell re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dd239cccb0236da5d119ad4b0f69c6e
https://doi.org/10.3892/ijo.12.5.1127
https://doi.org/10.3892/ijo.12.5.1127
Autor:
B M, Markaverich, T H, Schauweker, R R, Gregory, M, Varma, F S, Kittrell, D, Medina, R S, Varma
Publikováno v:
Cancer research. 52(9)
Methyl-p-hydroxyphenyllactate (MeHPLA) is a bioflavonoid and/or tyrosine metabolite which may regulate cellular growth and proliferation through interactions with nuclear type II sites. Our current studies suggest that type II sites may function as M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b43dd74864ce323c2303cc0dba92a31
https://pubmed.ncbi.nlm.nih.gov/1568218
https://pubmed.ncbi.nlm.nih.gov/1568218
Autor:
B M, Markaverich, R R, Gregory, M, Alejandro, F S, Kittrell, D, Medina, J H, Clark, M, Varma, R S, Varma
Publikováno v:
Cancer research. 50(5)
Previous studies in our laboratory demonstrated that methyl p-hydroxyphenyllactate (MeHPLA) is an important cell growth-regulating agent which binds to nuclear type II binding sites in normal and malignant cells. Furthermore, this compound is deficie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dbe88c106aacca3abc9c2f502c5cbb8a
https://pubmed.ncbi.nlm.nih.gov/2302712
https://pubmed.ncbi.nlm.nih.gov/2302712
Publikováno v:
Journal of Animal Science. 65:31-68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcb81986276799facc146ed6d9d76494
https://doi.org/10.1093/ansci/65.suppl_2.31
https://doi.org/10.1093/ansci/65.suppl_2.31
Publikováno v:
Cancer research. 42(11)
The studies presented here describe the effects of the nonionic detergent, Tween 80 and the reducing agent, dithiothreitol (5 mM), on the quantitation of specific nuclear estrogen binding sites, both estrogen receptors (ER) and type II estrogen bindi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::153018d3892723abc062f5cbe786e3a1
https://pubmed.ncbi.nlm.nih.gov/7127287
https://pubmed.ncbi.nlm.nih.gov/7127287
Autor:
B. M. Markaverich, J. H. Clark
Publikováno v:
Gene Regulation by Steroid Hormones III ISBN: 9781461291145
Previous studies from our laboratory have described two specific nuclear estrogen-binding sites in normal (Eriksson et al., 1978; Clark et al., 1978; Markaverich and Clark, 1979; Watson and Clark, 1980) and malignanttissues. Type I sites represent th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0103fdaa345dfef96eede3581b324d08
https://doi.org/10.1007/978-1-4612-4686-2_4
https://doi.org/10.1007/978-1-4612-4686-2_4
